CAR T Cell Therapy Patent - US12600775B2

Fri, 17 Apr 2026 07:31:17 +0000
Intellectual Property

USPTO granted Patent US12600775B2 to Kite Pharma, Inc. for methods of preparing, producing, processing, culturing, isolating, or making cells suitable for immune or cell therapy and their use in cell therapy. The patent covers CAR T cell therapy methods with applications in cancer treatment.